Biogen Idec Ltd: UK Public Sector Contracts Won & Awards

Large organisationCompanies House: Private Limited CompanyMaidenheadScotlandMain market: Pharmaceutical products

Official UK PPONPTGT-3385-PBMQCompanies House01497267 ↗ · Active

Where they win
i

53 awards (50 for a named lot, 94%, 3 for a whole procedure with no lot named) · top CPV classes, shares of all 53 awards. An award may cover more than one class.

3360 Pharmaceutical products51 awards · 96% · 48 awards naming a lot + 3 whole-procedure awards
Attributable award value
i
£37mOn 7 of 53 award records; the five largest make 98%. Largest rows below.
Typical attributable award
i
£949k middle valuerobust · n=7

Where their buyers are
i

ITL1 region of the buyer office · known for 38 of 38 awarded procedures · each procedure counts once

Greater London15 procedures · 39%
Scotland10 procedures · 26%
Wales (Cymru)5 procedures · 13%
Northern Ireland5 procedures · 13%
North West England3 procedures · 8%

Bidding record
i

Procurement Act 2023 award notices name every bidder · 4 notices name this supplier, covering 6 lots since 6 Oct 2025 · observed bids, not an estimate

Contract lots contested
i
0 won · 0 lostFewer than three decided lots: no rate is claimed.
Framework / DPS places
i
5 of 6Lots on 4 notices: a place is won per lot.
Authorities bid for
i
1

Bidder names come from Procurement Act 2023 award notices, which list every bidder (from 2025). Older notices name no bidders, so earlier contests do not appear here. Latest ten notices shown.

Who they sell to
i

Authorities named on this supplier’s published awards · ranked by distinct procedures · a framework or DPS adds one award record per appointed supplier

Authority type · official UK type when published, else name/id class, else not classified · by award records (a single panel can dominate)
i
  • NHS & health85%(45 awards)
    45 of 53 awards are NHS & health (85%).
  • Type not classified15%(8 awards)
    8 of 53 awards are Type not classified (15%).
AuthorityProceduresShareAward recordsLast activity
NHS Englandframework/DPS on 151539.5%236 Jul 2026
The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")framework/DPS on 91026.3%1430 Oct 2025
Regional Business Services Organisation Procurement and Logistics Serviceframework/DPS on 337.9%65 Jan 2026
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)framework/DPS on 137.9%315 Apr 2025
The NHS Commissioning Board (operating under the name of NHS England)framework/DPS on 337.9%37 Feb 2022
eTenderwales25.3%217 Jun 2025
Belfast Health and Social Care Trust25.3%218 Apr 2024

Share = of the 38 procedures with an award naming this supplier. Last activity = award date, or notice publication when no award date was published.

Contracts ending
i

37 of 53 awards carry an end date, 14 estimated from the duration · not a retender forecast

ContractEndsPublished value
Etanercept19 Jan 2027 estimated£1,700,000 ceiling
Infliximab IV19 Jan 2027 estimated£44,300,000 ceiling
Lot 1 - CM/PHS/25/5728/0131 May 2027£688,834,174 ceiling
Medicinal Products - Direct to Trust2 Jun 2027 estimated£210,000,000 ceiling
Medicinal Products - with Pharma Funded Homecare Services2 Jun 2027 estimated£174,000,000 ceiling
Glatiramer acetate solution for injection pre-filled syringes, interferon beta-1a, cladribine tablets, ozanimod capsules, and natalizumab28 Jun 2027 estimated£47,968,904 ceiling
Lot 2 - CM/PHR/25/5730/02 - Natalizumab for London and South of England31 Aug 2027£35,312,548 ceiling

Recent awards

Latest 30 of 53 award records naming this supplier

Award / procedureAuthorityAwardedPublished value
Ranibizumab vials and Pre-filled SyringesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")Not published£2,712,160 †
framework ceiling · 1 of 2 appointed suppliers
NHS Framework Agreement for Branded Medicines – Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025NHS EnglandNot published£1 †
framework ceiling · not attributable revenue
Proprietary DrugseTenderwalesNot published£948,600 †
from the contract notice
NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025NHS EnglandNot published£1 †
framework ceiling · not attributable revenue
Medicinal Products - Direct to TrustRegional Business Services Organisation Procurement and Logistics ServiceNot published£210,000,000 †
framework ceiling · 1 of 31 appointed suppliers
Medicinal Products - with Pharma Funded Homecare ServicesRegional Business Services Organisation Procurement and Logistics ServiceNot published£174,000,000 †
framework ceiling · 1 of 21 appointed suppliers
Biologic and Biosimilar MedicineseTenderwalesNot published£23,169,600 †
from the contract notice
Transitional Drugs 3NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)Not published£1,140,311 †
from the contract notice
Glatiramer acetate solution for injection pre-filled syringes, interferon beta-1a, cladribine tablets, ozanimod capsules, and natalizumabThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")Not published£47,968,904 †
framework ceiling · 1 of 6 appointed suppliers
EtanerceptThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")Not published£1,700,000 †
framework ceiling · 1 of 3 appointed suppliers
About this data
  • One profile per supplier. Built from award and contract notices that name this supplier; different spellings and registration numbers of the same company are merged into this profile.
  • Values are published values. The table mirrors what the notice published: framework ceilings and joint awards are labelled and never counted as this supplier's money, and † marks a value taken from the contract notice when the award published none. Only awards made to this supplier alone count towards its value, excluding VAT. It is not turnover.
  • Regions in the buyer chart describe the buyer office, not where the work is delivered or the supplier’s registered address.
  • Contract end dates. Published on 23 of 53 awards, estimated from the published duration on 14 more (marked “estimated”); those feed “Contracts ending”. Published values in that list come from either source; Contracts Finder figures are shown as published and stay out of this profile’s money totals.
  • Source. Official UK public procurement notices (Find a Tender and Contracts Finder), reused under the Open Government Licence v3.0, updated through the day and rebuilt nightly. Not every figure uses both feeds, and each one shows how many records it rests on: see the methodology. Spotted something wrong? Tell us.